Chengdu Shengnuo Biopharm Co., Ltd.
FDA inspection history in Chengdu, China, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Chengdu, China.
Cited most
Across all Chengdu Shengnuo Biopharm Co. observations on file
- 21 CFR 211.166Stability testing1
- 21 CFR 211.22Responsibilities of quality control unit1
The complete Chengdu Shengnuo Biopharm Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Chengdu, China
One Form 483 · 2023
Latest: Form 483, Sep 8, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-09-08 | 483 Form 483 | Chengdu, China | — | $99 |
Investigators on these documents
FEI number 3006257504 · most recent document Sep 8, 2023
About Chengdu Shengnuo Biopharm Co., Ltd.
How many FDA Form 483s has Chengdu Shengnuo Biopharm Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Chengdu Shengnuo Biopharm Co., Ltd.; the most recent is dated Sep 8, 2023.
When was Chengdu Shengnuo Biopharm Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Chengdu Shengnuo Biopharm Co., Ltd. is a Form 483 dated Sep 8, 2023, for the site in Chengdu, China.
What did FDA cite at Chengdu Shengnuo Biopharm Co., Ltd.?
The regulations cited most in the observations on file for Chengdu Shengnuo Biopharm Co., Ltd. are 21 CFR 211.166 (Stability testing), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time.